Graves disease is associated with increased risk of clinical Alzheimer’s disease: evidence from the Medicare system

被引：0
|
作者：
Arseniy Pavlovich Yashkin
Stanislav Kolpakov
Svetlana Ukraintseva
Anatoliy Yashin
Igor Akushevich
机构：
[1] Social Science Research Institute,Biodemography of Aging Research Unit
[2] Duke University,undefined
来源：
Clinical Diabetes and Endocrinology | / 10卷 / 1期
关键词：
Graves disease; Alzheimer’s disease; Hyperthyroidism; Dementia; Medicare;
D O I：
10.1186/s40842-024-00170-z
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] TREM2 is associated with increased risk for Alzheimer's disease in African Americans
    Jin, Sheng Chih
    Carrasquillo, Minerva M.
    Benitez, Bruno A.
    Skorupa, Tara
    Carrell, David
    Patel, Dwani
    Lincoln, Sarah
    Krishnan, Siddharth
    Kachadoorian, Michaela
    Reitz, Christiane
    Mayeux, Richard
    Wingo, Thomas S.
    Lah, James J.
    Levey, Allan I.
    Murrell, Jill
    Hendrie, Hugh
    Foroud, Tatiana
    Graff-Radford, Neill R.
    Goate, Alison M.
    Cruchaga, Carlos
    Ertekin-Taner, Niluefer
    MOLECULAR NEURODEGENERATION, 2015, 10
  • [32] ALZHEIMER'S DISEASE NOT ASSOCIATED WITH INCREASED RISK OF IN-HOSPITAL MORTALITY IN PULMONARY EMBOLISM
    Murthi, Mukunthan
    Ahuja, Kriti
    Atluri, Ramtej
    Velagapudi, Sujitha
    Velazquez, Genaro
    Sharma, Bharosa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1844 - 1844
  • [33] An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease
    Depboylu, C
    Lohmüller, F
    Gocke, P
    Du, Y
    Zimmer, R
    Gasser, T
    Klockgether, T
    Dodel, RC
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (03) : 170 - 173
  • [34] Interleukin-1α gene polymorphism is associated with increased risk of Alzheimer's disease
    Du, YS
    Gao, F
    Zhao, LM
    Farlow, M
    Dodel, R
    Hampel, H
    Faltraco, F
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S291 - S291
  • [35] Increased risk of Graves' disease after pregnancy
    Rochester, DB
    Davies, TF
    THYROID, 2005, 15 (11) : 1287 - 1290
  • [36] Alzheimer Biomarkers and Clinical Alzheimer Disease were Not Associated with Increased Cerebrovascular Disease in a Memory Clinic Population
    Spies, Petra E.
    Verbeek, Marcel M.
    Sjogren, Magnus J. C.
    de Leeuw, Frank-Erik
    Claassen, Jurgen A. H. R.
    CURRENT ALZHEIMER RESEARCH, 2014, 11 (01) : 40 - 46
  • [37] Evidence of increased neuronal dysfunction in Alzheimer's disease with psychosis
    Sweet, RA
    Klunk, WE
    Pettegrew, JW
    Hamilton, RL
    Lopez, OL
    Wisniewski, SR
    DeKosky, ST
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 143S - 143S
  • [38] Evidence against increased glycoxidation in patients with Alzheimer's disease
    Seidl, R
    Schuller, E
    Cairns, N
    Lubec, G
    NEUROSCIENCE LETTERS, 1997, 232 (01) : 49 - 52
  • [39] Further evidence of increased risk of mortality from Parkinson's disease
    Tison, F
    Letenneur, L
    Djossou, F
    Dartigues, JF
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (05): : 592 - 593
  • [40] Effects of the Medicare Alzheimer's disease demonstration on Medicare expenditures
    Newcomer, R
    Miller, R
    Clay, T
    Fox, P
    HEALTH CARE FINANCING REVIEW, 1999, 20 (04): : 45 - 65
12345